JERSEY SHORE UNIVERSITY MED CTR — History
CCN 310073 | 3-year financial timeline | COVID resilience: 87/100
🛡️ Public data only — no PHI permitted on this instance.
$1.2B
Latest Revenue (FY2022)
+15.3%
Revenue CAGR (3yr)
8.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $878M | $1.1B | $1.2B | +6.6% | +15.3% |
| Operating Expenses | $956M | $1.1B | $1.1B | +0.3% | +5.8% |
| Operating Margin | -8.8% | 2.7% | 8.4% | +210.5% | +0.0% |
| Net Income | $-78M | $30M | $98M | +231.0% | +0.0% |
| Licensed Beds | 566 | 572 | 604 | +5.6% | +3.3% |
| Total Patient Days | 144,080 | 164,101 | 171,884 | +4.7% | +9.2% |
| Medicare Day % | 40% | 37% | 37% | -0.9% | -3.6% |
| Medicaid Day % | 6% | 4% | 4% | +0.5% | -19.8% |
COVID Impact & Recovery
Resilience Score: 87/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +33.0% ($878M → $1.2B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+15.3%
This Hospital
+7.6%
State Avg
Latest Margin
8.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $1.3B | 17.0% |
| FY2024 (proj) | $1.5B | 25.7% |
| FY2025 (proj) | $1.6B | 34.3% |